IL17A and metabolic dysfunction-associated steatohepatitis: Patients with MASH were significantly more likely to have a variant genotype (A/G + G/G) of IL17-A7448G gene polymorphism (corrected p = 0.0338), variant genotype (G/A + A/A) of IL17-G197A gene polymorphism (corrected p = 0.0008), variant genotype (Asp/Gly + Gly/Gly) of TLR4-Asp299Gly gene polymorphism (corrected p = 0.0338), or variant genotype (Thr/Ile + Ile/Ile) of TLR4-Thr399Ile gene polymorphism (corrected p = 0.0138).